| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S1473-3099(04)00971-5 |
| P698 | PubMed publication ID | 15050939 |
| P50 | author | Katleen de Gaetano Donati | Q87723140 |
| Licia Iacoviello | Q40806254 | ||
| Roberto Cauda | Q56383721 | ||
| P2093 | author name string | Ricardo Rabagliati | |
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors | Q28196283 | ||
| Inflammatory cell adhesion molecules in ischemic cerebrovascular disease | Q28216745 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
| Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance | Q31831918 | ||
| Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? | Q33184007 | ||
| Infection and atherosclerosis: emerging mechanistic paradigms | Q33696699 | ||
| Plasminogen-activator inhibitor type 1 and coronary artery disease | Q33942520 | ||
| Coronary artery disease and human immunodeficiency virus infection | Q34052597 | ||
| The effects of HIV infection on endothelial function | Q34153342 | ||
| A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2 | Q34185817 | ||
| Interactions between endothelial cells and HIV-1. | Q34225087 | ||
| Fundamentals of endothelial function for the clinical cardiologist | Q34517868 | ||
| Pathogenesis of HIV-associated cardiovascular complications | Q34547836 | ||
| Thiazolidinediones could improve endothelial dysfunction and risk of premature coronary heart disease in HIV-infected patients | Q35030013 | ||
| Endothelial dysfunction: a marker of atherosclerotic risk | Q35067247 | ||
| Effects of statins on inflammation in patients with acute and chronic coronary syndromes | Q35077214 | ||
| Pathogenesis of HIV-associated heart disease. | Q35180729 | ||
| Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. | Q35180758 | ||
| Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review. | Q35226533 | ||
| Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients | Q37400137 | ||
| Host factors in the pathogenesis of HIV disease | Q38949921 | ||
| Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients. | Q39223341 | ||
| Circulating endothelial progenitor cells, vascular function, and cardiovascular risk | Q39513285 | ||
| HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages | Q39740926 | ||
| A reliable marker of endothelial cell dysfunction: does it exist? | Q40401880 | ||
| CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. | Q40658295 | ||
| Circulating cell adhesion molecules and death in patients with coronary artery disease | Q40686123 | ||
| HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells | Q40697876 | ||
| Soluble P-selectin and the risk of future cardiovascular events | Q40729226 | ||
| HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells | Q40744516 | ||
| CD40 ligand--assessing risk instead of damage? | Q73149298 | ||
| Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1 | Q73229612 | ||
| Coronary heart disease in HIV-infected individuals | Q73687564 | ||
| Serial changes in plasma levels of soluble P-selectin in patients with acute myocardial infarction | Q74251441 | ||
| Soluble form of selectins in blood of patients with acute myocardial infarction and coronary intervention | Q74453668 | ||
| HIV infection and cardiovascular disease--is there really a link? | Q79308577 | ||
| Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. | Q40872170 | ||
| Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study | Q40873641 | ||
| Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection | Q41020979 | ||
| Multifunctional cytokine expression by human coronary endothelium and regulation by monokines and glucocorticoids | Q41027080 | ||
| Endogenous tissue-type plasminogen activator and risk of myocardial infarction | Q41079493 | ||
| Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? | Q41469163 | ||
| Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progression | Q41534487 | ||
| AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen | Q41830365 | ||
| HIV antigen in the brains of patients with the AIDS dementia complex | Q42516851 | ||
| Sustained benefits of metformin therapy on markers of cardiovascular risk in human immunodeficiency virus-infected patients with fat redistribution and insulin resistance | Q42684893 | ||
| Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy | Q43556074 | ||
| A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors | Q43613003 | ||
| Infection of the retina by human immunodeficiency virus type I. | Q43634339 | ||
| Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction | Q43678570 | ||
| Hypofibrinolytic state in HIV-1-infected patients treated with protease inhibitor-containing highly active antiretroviral therapy | Q43974563 | ||
| Bezafibrate-induced improvement in glucose uptake and endothelial function in protease inhibitor-associated insulin resistance | Q44242901 | ||
| Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy | Q44342147 | ||
| Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study | Q44486385 | ||
| Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants | Q44508807 | ||
| Combination antiretroviral therapy and the risk of myocardial infarction | Q44662157 | ||
| Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection | Q45729086 | ||
| Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients. | Q45729419 | ||
| Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. | Q45733605 | ||
| Productive in vitro infection of human umbilical vein endothelial cells and three colon carcinoma cell lines with HIV-1. | Q46211469 | ||
| Haptoglobin polymorphism, iron metabolism and mortality in HIV infection | Q47853455 | ||
| Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release | Q47925160 | ||
| HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas | Q48599233 | ||
| Increased levels of soluble P-selectin in hypercholesterolemic patients. | Q50898407 | ||
| Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study | Q57830053 | ||
| Protease inhibitors and cardiovascular outcomes in patients with HIV-1 | Q57955538 | ||
| Productive HIV-1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin-1 beta plus tumor necrosis factor-alpha | Q61649160 | ||
| Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy | Q61944960 | ||
| Immune function of vascular endothelial cells is impaired by HIV | Q69742574 | ||
| Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction | Q69901572 | ||
| Levels of the circulating cell adhesion molecule E-selectin and disease progression in HIV infection | Q70789305 | ||
| Interferon gamma stimulates cell-mediated transmission of HIV type 1 from abortively infected endothelial cells | Q71352541 | ||
| Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry | Q71467046 | ||
| Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections | Q71535844 | ||
| The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis | Q71605264 | ||
| HIV-1 induces tumour necrosis factor and IL-1 gene expression in primary human macrophages independent of productive infection | Q71615108 | ||
| Increased soluble form of P-selectin in patients with unstable angina | Q71709857 | ||
| HIV-1 infection induces functional alterations in human liver endothelial cells in primary culture | Q72188975 | ||
| Elevated serum levels of circulating intercellular adhesion molecule-1 in HIV infection | Q72221356 | ||
| Increased levels of serum intercellular adhesion molecule 1 in HIV infection are related to immune activation | Q72233459 | ||
| Serum concentrations of soluble intercellular adhesion molecule-1 and progress towards disease in patients infected with HIV | Q72615639 | ||
| Cardiovascular risk factors and antiretroviral therapy | Q73020231 | ||
| Evidence of prolonged inflammation in unstable angina and non-Q wave myocardial infarction | Q73069714 | ||
| P433 | issue | 4 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 213-222 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | HIV infection, HAART, and endothelial adhesion molecules: current perspectives | |
| P478 | volume | 4 |
| Q38036194 | A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia |
| Q46333565 | A comparison of the association between glomerular filtration and L-arginine status in HIV-infected and uninfected African men: the SAfrEIC study. |
| Q44699469 | Angina pectoris in patients with HIV/AIDS: prevalence and risk factors |
| Q37439900 | Antiretroviral treatment interruptions and risk of non-opportunistic diseases |
| Q48340174 | Atherosclerosis and central adiposity in a pediatric patient with AIDS treated with HAART: autopsy findings |
| Q34335486 | Biomarkers and HIV-associated cardiovascular disease |
| Q38377965 | CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies |
| Q53854336 | Cardiovascular and Endothelial Disease in HIV Infection. |
| Q36408675 | Cardiovascular disease in HIV infection |
| Q46792927 | Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. |
| Q37381433 | Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study |
| Q92857687 | Characterization of Leukocytes From HIV-ART Patients Using Combined Cytometric Profiles of 72 Cell Markers |
| Q33604765 | Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors |
| Q55006413 | Detection of HIV-1 and Human Proteins in Urinary Extracellular Vesicles from HIV+ Patients. |
| Q28543075 | Differential adipose tissue gene expression profiles in abacavir treated patients that may contribute to the understanding of cardiovascular risk: a microarray study |
| Q38911295 | Efavirenz Causes Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Endothelial Cells |
| Q38130907 | Endocrine and metabolic abnormalities among HIV-infected patients: a current review |
| Q34241388 | Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy |
| Q56529497 | HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy |
| Q55210420 | HIV Infection, Antiretroviral Therapy and Cardiovascular Risk. |
| Q54208962 | HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana. |
| Q37073341 | HIV infection and cardiovascular risk in black South Africans. |
| Q36285922 | HIV infection and stroke: current perspectives and future directions |
| Q35989740 | HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction |
| Q33556997 | High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection |
| Q37356774 | How does HIV impact on non-AIDS events in the era of HAART? |
| Q35176441 | Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution |
| Q38603237 | Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy |
| Q37042012 | Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa? |
| Q43241598 | Lipid abnormalities in a never-treated HIV-1 subtype C-infected African population |
| Q35148915 | Lipodystrophy: pathophysiology and advances in treatment |
| Q36377944 | Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV. |
| Q38495100 | Nanoparticles functionalized with supramolecular host-guest systems for nanomedicine and healthcare. |
| Q46130631 | Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells |
| Q34766189 | Persistent inflammation and endothelial activation in HIV-1 infected patients after 12 years of antiretroviral therapy |
| Q45887320 | Population pharmacokinetics of recombinant factor VIII:C (ReFacto) in adult HIV-negative and HIV-positive haemophilia patients |
| Q39743645 | Power spectral analysis of heart rate variability in HIV-infected and AIDS patients |
| Q48206030 | Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age. |
| Q28067891 | Role of high-sensitivity C-reactive protein measurements in HIV patients |
| Q39944588 | SOLUBLE CD40 LIGAND IN DEMENTIA. |
| Q42234346 | Safety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus. |
| Q47315709 | Stimulated release of size-selected cargos in succession from mesoporous silica nanoparticles. |
| Q35089263 | Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease |
| Q92885360 | Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection |
| Q54260140 | The Dual Role of Neutrophils in HIV Infection. |
| Q37429096 | The Relationship Between HIV Infection and Cardiovascular Disease |
| Q37355492 | The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study |
| Q33889580 | The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms |
| Q37186467 | The role of HIV in serious diseases other than AIDS. |
| Q35917538 | Treatment of HIV infection in the older patient |
| Q88733762 | Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy |
| Q37393762 | Untreated HIV infection and large and small artery elasticity |
| Q47563724 | When do models of NeuroAIDS faithfully imitate "the real thing"? |
| Q82979629 | [Patient-related cardiovascular risk factors in the HIV-infected population] |
Search more.